We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$113B
1-Year Est. Return
38.87%
This Fund
S&P 500
This Quarter
Est. Return
+2.73%
1 Year Est. Return
+38.87%
3 Year Est. Return
+108.29%
5 Year Est. Return
+142.95%
10 Year Est. Return
+500.61%
AUM
$67.2B
AUM Growth
+$540M
(+0.81%)
Cap. Flow
-$425M
Cap. Flow
% of AUM
-0.63%
Top 10 Holdings %
Top 10 Hldgs %
16.83%
Holding
780
New
63
Increased
245
Reduced
379
Closed
79
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$840M |
| 2 |
RTX Corp
RTX
|
+$638M |
| 3 |
Trane Technologies
TT
|
+$326M |
| 4 |
APC
Anadarko Petroleum
APC
|
+$299M |
| 5 |
Gilead Sciences
GILD
|
+$274M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$489M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$397M |
| 3 |
ExxonMobil
XOM
|
+$325M |
| 4 |
Comcast
CMCSA
|
+$322M |
| 5 |
TWX
Time Warner Inc
TWX
|
+$293M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 24.95% |
| 2 | Healthcare | 16.68% |
| 3 | Technology | 16.63% |
| 4 | Industrials | 11.79% |
| 5 | Consumer Discretionary | 8.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
Omnicell
OMCL
$1.51B
| $2.99M | ﹤0.01% |
85,212
-7,220
| -8% | -$238K |
|
|
NTLS
577
DELISTED
NTELOS HLDGS CORP COM
NTLS
| $2.99M | ﹤0.01% |
622,762
-48,745
| -7% | -$230K |
|
578
Charles River Laboratories
CRL
$14B
| $2.96M | ﹤0.01% |
37,394
-8,615
| -19% | -$636K |
|
|
NXH
579
Neighborhood Intelligence Inc
NXH
$376M
| $2.93M | ﹤0.01% |
+160,942
| New | +$2.79M |
|
|
TRK
580
DELISTED
Speedway Motorsports, Inc.
TRK
| $2.92M | ﹤0.01% |
128,550
-9,741
| -7% | -$220K |
|
581
Destination XL Group
DXLG
$34.4M
| $2.89M | ﹤0.01% |
584,887
-33,150
| -5% | -$164K |
|
|
TPH
582
DELISTED
Tri Pointe Homes
TPH
| $2.88M | ﹤0.01% |
186,784
+52,060
| +39% | +$782K |
|
583
AMERISAFE
AMSF
$491M
| $2.88M | ﹤0.01% |
62,251
-5,365
| -8% | -$227K |
|
|
BBRG
584
DELISTED
Bravo Brio Restaurant Group Inc.
BBRG
| $2.86M | ﹤0.01% |
194,530
+176,243
| +964% | +$2.42M |
|
|
JOY
585
DELISTED
Joy Global Inc
JOY
| $2.75M | ﹤0.01% |
70,251
-5,502
| -7% | -$233K |
|
586
POSCO
PKX
$18.1B
| $2.67M | ﹤0.01% |
48,876
-3,774
| -7% | -$230K |
|
587
United Parks & Resorts
PRKS
$1.92B
| $2.67M | ﹤0.01% |
138,543
-78,768
| -36% | -$1.45M |
|
588
Annaly Capital Management
NLY
$17.4B
| $2.65M | ﹤0.01% |
63,805
-4,993
| -7% | -$212K |
|
|
MNR
589
DELISTED
Monmouth Real Estate Investment Corp
MNR
| $2.62M | ﹤0.01% |
235,919
-23,974
| -9% | -$275K |
|
|
GUID
590
DELISTED
Guidance Software, Inc.
GUID
| $2.62M | ﹤0.01% |
484,343
+32,241
| +7% | +$198K |
|
591
Dawson Geophysical
DWSN
$104M
| $2.6M | ﹤0.01% |
640,365
+144,139
| +29% | +$779K |
|
|
NWLIA
592
DELISTED
NATL WESTN LIFE INS CO CL A
NWLIA
| $2.58M | ﹤0.01% |
10,165
-784
| -7% | -$199K |
|
593
Archer Daniels Midland
ADM
$38.6B
| $2.52M | ﹤0.01% |
53,097
-22,658
| -30% | -$1.08M |
|
|
XOXO
594
DELISTED
Xo Group Inc
XOXO
| $2.51M | ﹤0.01% |
142,104
-15,251
| -10% | -$258K |
|
|
CNBKA
595
DELISTED
Century Bancorp Inc/Mass
CNBKA
| $2.49M | ﹤0.01% |
62,676
-3,617
| -5% | -$142K |
|
|
USAP
596
DELISTED
Universal Stainless & Alloy
USAP
| $2.49M | ﹤0.01% |
94,868
-7,345
| -7% | -$172K |
|
597
ePlus
PLUS
$2.28B
| $2.47M | ﹤0.01% |
113,740
-223,472
| -66% | -$4.35M |
|
598
Genesco
GCO
$372M
| $2.45M | ﹤0.01% |
+34,338
| New | +$2.49M |
|
599
APA Corp
APA
$14.8B
| $2.41M | ﹤0.01% |
39,891
-25,557
| -39% | -$1.61M |
|
|
OKSB
600
DELISTED
Southwest Bancorp Inc/OK
OKSB
| $2.4M | ﹤0.01% |
134,690
+610
| +0.5% | +$10.1K |
|
Similar funds
Boston Partners's Q1 2015 Portfolio in Review
As of Q1 2015, Boston Partners held 780 positions worth $67.2B, up 0.81% from $66.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Boston Partners's Q1 2015 filing shows 63 new, 245 increased, 379 reduced and 79 closed positions. Its largest new stake was Merck: 14,837,117 shares worth $814M. The largest sale was Citigroup, an estimated $489M.
By sector, the portfolio is most concentrated in Financials at 25% of assets, down from 27% a quarter earlier, followed by Healthcare and Technology.
- Boston Partners's largest Q1 2015 buy was Merck: 14,837,117 shares worth $814M.
- Boston Partners added most to RTX Corp in Q1 2015, an estimated $638M increase.
- Boston Partners's biggest Q1 2015 reduction was Citigroup, cutting an estimated $489M.
- Boston Partners fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q1 2015, selling an estimated $397M.
- Boston Partners's ten largest holdings make up 17% of its $67.2B portfolio in Q1 2015.
- Boston Partners opened 63 new positions and closed 79 in Q1 2015.
- Boston Partners's portfolio value rose 0.81% quarter-over-quarter to $67.2B.
Based on Boston Partners's 13F filing for Q1 2015, filed 5 May 2015.